ADAR1 Capital Management, LLC

Insider Reports History

Location
3503 Wild Cherry Drive, Building 9, Austin, TX
Signature
ADAR1 Capital Management, LLC By: Daniel Schneeberger, Manager /s/ Daniel Schneeberger
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ADAR1 Capital Management, LLC:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PIERIS PHARMACEUTICALS, INC. 10%+ Owner Common Stock 130K $2.06M $15.88 Aug 12, 2024 By: ADAR1 Partners
PIERIS PHARMACEUTICALS, INC. 10%+ Owner Common Stock 15.1K $239K $15.88 Aug 12, 2024 By: Spearhead Insurance Solutions IDF, LLC - Series ADAR1
Keros Therapeutics, Inc. 10%+ Owner Common Stock 0 $0 $17.75 Oct 15, 2025 By ADAR1 Partners, LP
Keros Therapeutics, Inc. 10%+ Owner Common Stock 0 $0 $17.75 Oct 15, 2025 By ADAR1 SPVI, LP
Keros Therapeutics, Inc. 10%+ Owner Common Stock 0 $0 $17.75 Oct 15, 2025 By Spearhead Insurance Solutions IDF, LLC
Acasti Pharma Inc. 10%+ Owner Class A Common Stock 960K Jun 28, 2024 By: ADAR1 Partners
Keros Therapeutics, Inc. 10%+ Owner Cash Settled Total Return Swaps 50K Apr 9, 2025 By ADAR1 Partners, LP
Keros Therapeutics, Inc. 10%+ Owner Put Option (obligation to buy) 0 May 16, 2025 By ADAR1 Partners, LP
Keros Therapeutics, Inc. 10%+ Owner Put Option (obligation to buy) 0 May 16, 2025 By Spearhead Insurance Solutions IDF, LLC
Keros Therapeutics, Inc. 10%+ Owner Put Option (right to sell) 0 Jun 20, 2025 By ADAR1 Partners, LP
Keros Therapeutics, Inc. 10%+ Owner Put Option (right to sell) 0 Jun 20, 2025 By Spearhead Insurance Solutions IDF, LLC

Insider Reports Filed by ADAR1 Capital Management, LLC

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KROS Keros Therapeutics, Inc. Oct 15, 2025 3 -$95.7M 4 Oct 15, 2025 10%+ Owner
KROS Keros Therapeutics, Inc. Jun 20, 2025 6 -$118K 4 Jun 24, 2025 10%+ Owner
KROS Keros Therapeutics, Inc. May 16, 2025 3 $0 4 Jun 12, 2025 10%+ Owner
KROS Keros Therapeutics, Inc. Apr 9, 2025 8 $9.46M 4 Apr 11, 2025 10%+ Owner
KROS Keros Therapeutics, Inc. Apr 8, 2025 0 $0 3 Apr 11, 2025 10%+ Owner
PIRS PIERIS PHARMACEUTICALS, INC. Aug 9, 2024 3 $92.3K 4 Aug 12, 2024 10%+ Owner
PIRS PIERIS PHARMACEUTICALS, INC. Jul 24, 2024 0 $0 3 Jul 31, 2024 10%+ Owner
ACST Acasti Pharma Inc. Jun 28, 2024 0 $0 3/A Jul 11, 2024 10%+ Owner
ACST Acasti Pharma Inc. Jun 28, 2024 0 $0 3 Jul 9, 2024 10%+ Owner